Proton pump inhibitors reduce gallbladder function

Surgical Endoscopy and Other Interventional Techniques

Volumn 20, Issue 9, 2006, Pages 1364-1367

  Cahan, M A ^a,b   Balduf, L ^a   Colton, K ^a   Palacioz, B ^a   McCartney, W ^a   Farrell, T M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Biliary dyskinesia; Gallbladder ejection fraction; Gastrin; GERD; Proton pump inhibitors

Indexed keywords

CHOLECYSTOKININ; OMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ABDOMINAL PAIN; ADULT; ARTICLE; BILIARY EXCRETION; BILIARY TRACT DISEASE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FLATULENCE; GALLBLADDER DYSMOTILITY; GALLBLADDER FUNCTION; GALLBLADDER MOTILITY; HEPATOBILIARY SCINTISCANNING; HUMAN; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; VOMITING;

ADULT; ENZYME INHIBITORS; FEMALE; GALLBLADDER; GASTROINTESTINAL DISEASES; HUMANS; MALE; MOVEMENT; OMEPRAZOLE; PROTON PUMPS; REFERENCE VALUES;

EID: 33749016042     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-005-0247-x     Document Type: Article

References (27)

1. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ (2001) No association between gallstones and gastroesophageal reflux disease. Am J Gastroenterol 96: 2858-2862
2. Bardhan KD (1999) Pantoprazole: a new proton pump inhibitor in the management of upper gastrointestinal disease. Drugs Today (Barc) 35: 773-808
3. Bucceri AM, Calogero AE, Brogna A (2002) Gallbladder and gastric emptying: relationship to cholecystokininemia in diabetics. Eur J Intern Med 13: 123-128
4. Cadiot G, Vissuzaine C, Pospai D, Ruszniewski P, Potet F, Mignon M(1995) Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa: preliminary results. Gastroenterol Clin Biol 19: 811-817
5. Capron JP, Payenneville H, Dumont M, Dupas JL, Lorriaux A (1978) Evidence for an association between cholelithiasis and hiatus hernia. Lancet 2: 329-331
6. Cattey RP, Wilson SD (1989) Cholelithiasis follows total gastrectomy in Zollinger-Ellison syndrome. Surgery 106: 1070-1073
7. Chowdhury JR, Berkowitz JM, Praissman M, Fara JW (1975) Interaction between octapeptide-cholecystokinin, gastrin, and secretin on cat gallbladder in vitro. Am J Physiol 229: 1311-1315
8. Chowdhury JR, Berkowitz JM, Praissman M, Fara JW (1976) Effect of sulfated and nonsulfated gastrin and octapeptide-cholecystokinin on cat gall bladder in vitro. Experientia 32: 1173-1175
9. DiBaise JK, Oleynikov D (2003) Does gallbladder ejection fraction predict outcome after cholecystectomy for suspected chronic acalculous gallbladder dysfunction? A systematic review. Am J Gastroenterol 98: 2605-2611
10. Festen HP, Thijs JC, Lamers CB, Jansen JM, Pals G, Frants RR, Defize J, Meuwissen SG (1984) Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 87: 1030-1034
11. Gallup Organization (1988) A Gallup Organization National Survey: Heartburn Across America. Gallup Organization, Princeton, NJ
12. Grider JR, Makhlouf GM (1990) Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am J Physiol 259: G184-G190
13. Koop H, Klein M, Arnold R (1990) Serum gastrin levels during long-term omeprazole treatment. Aliment Pharm Ther 4: 131-138
14. Krishnamurthy GT, Krishnamurthy S, Brown PH (2004) Constancy and variability of gallbladder ejection fraction: impact on diagnosis and therapy. J Nucl Med 45: 1872-1877
15. Krishnamurthy S, Krishnamurthy GT (1997) Biliary dyskinesia: role of the sphincter of Oddi, gallbladder, and cholecystokinin. J Nucl Med 38: 1824-1830
16. Manifold DK, Anggiansah A, Owen WJ (2000) Effect of cholecystectomy on gastroesophageal and duodenogastric reflux. Am J Gastroenterol 95: 2746-2750
17. Morton JM, Bowers SP, Lucktong TA, Mattar S, Bradshaw WA, Behrns KE, Koruda MJ, Herbst CA, McCartney W, Halkar RK, Smith CD, Farrell TM (2002) Gallbladder function before and after fundoplication. J Gastrointest Surg 6: 806-810
18. Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H (2004) Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with Helicobacter pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Hepatogastroenterology 51: 338-342
19. Portincasa P, Di Ciaula A, Palmieri V, Velardi A, VanBerge-Henegouwen GP, Palasciano G (1997) Impaired gallbladder and gastric motility and pathological gastro-oesophageal reflux in gallstone patients. Eur J Clin Invest 27: 653-661
20. Rasmussen L, Oster-Jorgensen E, Qvist N, Hovendal CP, Kraglund K, Olsen O, de Schaffalitzky Muckadell OB, Rehfeld J, Pedersen SA (1992) The effects of omeprazole on interdigestive motility and early postprandial levels of gastrin and secretin. Scan J Gastroenterol 27: 119-123
21. Rasmussen L, Qvist N, Oster-Jorgensen E, Rehfeld JF, Holst JJ, Pedersen SA (1997) A double-blind placebo-controlled study of the effects of omeprazole on gut hormone secretion and gastric emptying rate. Scand J Gastroenterol 32: 900-905
22. Ryan J, Cohen S (1976) Gallbladder pressure-volume response to gastrointestinal hormones. Am J Physiol 230: 1461-1465
23. Schjoldager BT (1994) Role of CCK in gallbladder function. Ann NY Acad Sci 713: 207-218
24. Toouli J, Hogan WJ, Geenen JE, Dodds WJ, Arndorfer RC (1982) Action of cholecystokinin octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans. Surgery 92: 497-503
25. Vaczek D (2003) Top 200 drugs of 2002. Pharm Times, April p 20
26. Valenzuela JE, Walsh JH, Isenberg JI (1976) Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man. Gastroenterology 71: 409-411
27. Watson S, Arkinstall S (1994) Cholecystokinin (CCK) and gastrin. In: Watson S, Arkinstall S (eds). The G Protein-Linked Receptor Factsbook. Academic Press, London, pp 89-95